{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01545",
      "entity_text" : "EGFR-TKI",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01534",
      "entity_text" : "icotinib",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "However, quinalizarin enhanced the suppression of cell viability mediated by icotinib in A549, H1650 and H1975 cell lines, which were shown to be primary or secondary EGFR-TKI resistant cell lines.",
  "reading_complete" : "2020-08-03T13:31:13Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:30:16Z",
  "trigger" : "mediated",
  "evidence" : [ "mediated by icotinib in A549, H1650 and H1975 cell lines, which were shown to be primary or secondary EGFR-TKI" ],
  "pmc_id" : "6605624",
  "score" : 0
}